Prognostic value of intact and cleaved forms of the urokinase plasminogen activator receptor in a retrospective study of 518 colorectal cancer patients

Prognostic significance of urokinase plasminogen activator receptor and its cleaved forms in blood from patients with non-small cell lung cancer

(2009) CHARLOTTE ELBERLING ALMASI et al.   APMIS

Intact and cleaved forms of the urokinase receptor enhance discrimination of cancer from non-malignant conditions in patients presenting with symptoms related to colorectal cancer

(2009) A F Lomholt et al.   BRITISH JOURNAL OF CANCER

Cleaved Forms of the Urokinase Plasminogen Activator Receptor in Plasma Have Diagnostic Potential and Predict Postoperative Survival in Patients with Ovarian Cancer

(2008) E. Henic et al.   CLINICAL CANCER RESEARCH

National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines for Use of Tumor Markers in Testicular, Prostate, Colorectal, Breast, and Ovarian Cancers

(2008) C. M. Sturgeon et al.   CLINICAL CHEMISTRY

Two distinct expression patterns of urokinase, urokinase receptor and plasminogen activator inhibitor-1 in colon cancer liver metastases

(2008) Martin Illemann et al.   INTERNATIONAL JOURNAL OF CANCER

Preoperative staging of rectal cancer

(2007) Neil Smith et al.   ACTA ONCOLOGICA